Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
37%
OVERLAP
BY WEIGHT
51
# OF OVERLAPPING
HOLDINGS
IHE
55
HOLDINGS
100%
ALSO IN XPH
XPH
60
HOLDINGS
86%
ALSO IN IHE
SECTOR DRIFT (IHE minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
CRINETICS PHARMACEUTICALS INC | 2.0% | 3.7% | 2.0% |
|
CORCEPT THERAPEUTICS INC | 2.0% | 1.9% | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 4.6% | 1.7% | 1.7% |
 |
JAZZ PHARMACEUTICALS PLC | 3.5% | 1.7% | 1.7% |
|
JOHNSON & JOHNSON | 22.6% | 1.7% | 1.7% |
IHE Overweight Relative to XPH
|
JOHNSON & JOHNSON | 20.9% |
|
ELI LILLY & CO | 19.9% |
|
BRISTOL-MYERS SQUIBB CO | 2.9% |
|
MERCK & CO. INC. | 2.8% |
|
VIATRIS, INC. | 2.8% |
|
ROYALTY PHARMA PLC CLASS A | 2.8% |
|
PFIZER INC | 2.5% |
|
ZOETIS INC | 2.4% |
|
JAZZ PHARMACEUTICALS PLC | 1.9% |
|
ELANCO ANIMAL HEALTH, INC. | 1.1% |
IHE Underweight Relative to XPH
|
MBX BIOSCIENCES INC | -2.7% |
|
NUVATION BIO INC CLASS A | -1.8% |
|
CRINETICS PHARMACEUTICALS INC | -1.7% |
|
AMYLYX PHARMACEUTICALS, INC. | -1.7% |
|
ALUMIS INC | -1.6% |
|
DEFINIUM THERAPEUTICS INC | -1.6% |
|
MAZE THERAPEUTICS INC | -1.5% |
|
ENLIVEN THERAPEUTICS, INC. | -1.5% |
|
TREVI THERAPEUTICS, INC. | -1.5% |
|
ETON PHARMACEUTICALS, INC. | -1.5% |